DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20221184
Published: 2022-04-26

Prevalence of diabetes mellitus among tuberculosis patients attending a directly observed treatment-short-course center in Delhi, India

Sunom M. Lepcha, Anita Khokhar, Priyanka Sharma

Abstract


Background: Diabetes (DM) can worsen the clinical course of tuberculosis (TB) and treatment outcomes in terms of increased deaths, treatment failure, and relapse rates. This study investigated the prevalence of DM in TB patients at an urban primary health centre (UPHC), Delhi and the factors associated with it.

Methods: A record-based study of all TB patients registered from December 2019 to November 2020 at a directly observed treatment short-course (DOTS) center of a UPHC in Delhi was conducted. Information regarding socio-demographic details and disease profile, diabetes status and random blood sugar level was collected from patients’ treatment cards. Data were entered and analyzed in SPSS. Descriptive analysis was done.

Results: A total of 252 patients were registered at the DOTS center during one year and data for all of them were analyzed. The mean age of the study participants at the time of the study was 31.13±15.84 years, half of them were males (56%) and the site of the disease was predominantly pulmonary (61%). Out of 252 TB patients, 17 (7%) and 2 (1%) were diabetics and pre-diabetics respectively.

Conclusions: Those patients with age more than 30 years, pulmonary TB, sputum positive TB are the factors with statistically significant association with diabetes in our study.


Keywords


Diabetes mellitus, Tuberculosis, DOTS

Full Text:

PDF

References


World Health Organization. Global Tuberculosis Report 2020. Available at: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf. Accessed on 19 January 2019.

Ministry of health and family welfare. Central TB Division. India TB report 2019. Available at: https://tbcindia.gov.in/WriteReadData/India%20TB%20Report%202019.pdf. Accessed on 19 January 2021.

Marais BJ, Lönnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis. 2013;13(5):436-48.

International Diabetes Federation. IDF SEA members. Available at: https://idf.org/our-network/regions-members/south-east-asia/members/94-india.html. Accessed on 19 January 2019.

World Health Organization. The dual epidemic of TB and Diabetes. Available at: https://www.who.int/tb/publications/diabetes_tb.pdf. Accessed on 19 January 2019.

Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9(1):81.

World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of WHO Consultation Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization; 1999.

Poverty line in Delhi. Available at: http://delhiplanning.nic.in/sites/default/files/20%29%20Poverty%20Line%20in%20Delhi.pdf. Accessed on 19 January 2019.

Nagar V, Prasad P, Gour D, Singh AR, Pal DK. Screening for diabetes among tuberculosis patients registered under revised national tuberculosis control program, Bhopal, India. J Family Med Prim Care. 2018;7(6):1401-5.

Sembiah S, Nagar V, Gour D, Pal DK, Mitra A, Burman J. Diabetes in tuberculosis patients: An emerging public health concern and the determinants and impact on treatment outcome. J Family Community Med. 2020;27(2):91-6.

Siddiqui AN, Khayyam KU, Sharma M. Effect of Diabetes Mellitus on Tuberculosis Treatment Outcome and Adverse Reactions in Patients Receiving Directly Observed Treatment Strategy in India: A Prospective Study. Biomed Res Int. 2016;2016:7273935.

Masharani U. Diabetes Mellitus and hypoglycaemia. In: Current Medical Diagnosis and treatment, 60th ed. Papadakis MA, Mcphee SJ, Rabow MW, editors. New York: McGraw-hill. 2020;1243.

Khanna A, Lohya S, Sharath BN, Harries AD. Characteristics and treatment response in patients with tuberculosis and diabetes mellitus in New Delhi, India. Public Health Action. 2013;3(Suppl 1):S48-50.

Refaie MR, Sayed-Ahmed NA, Bakr AM, Aziz MY, El Kannishi MH, Abdel-Gawad SS. Aging is an inevitable risk factor for insulin resistance. Journal of Taibah University Medical Sciences. 2006;1(1):30-41.

Tramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, Montagner A, Gourdy P. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020;63(3):453-61.

Ramezankhani A, Azizi F, Hadaegh F. Associations of marital status with diabetes, hypertension, cardiovascular disease and all-cause mortality: a long term follow-up study. PloS one. 2019;14(4):e0215593.

Viswanathan V, Kumpatla S, Aravindalochanan V, Rajan R, Chinnasamy C, Srinivasan R et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One. 2012;7(7):e41367.

Das S, Das E, Bhuyan K, Prusty B, Barik M, Yadav VS, et al. Bi-directional screening of tuberculosis patients for type 2 diabetes mellitus and diabetes patients for tuberculosis in Bhubaneswar, Odisha. Int J Community Med Public Health. 2017;4:2435-42.

Restrepo BI. Diabetes and tuberculosis. Understanding the Host Immune Response against Mycobacterium Tuberculosis Infection. 2018;1-21.

Agarwal AK, Gupta G, Marskole P, Agarwal A. A Study of the Patients Suffering from Tuberculosis and Tuberculosis-diabetes Comorbidity in Revised National Tuberculosis Control Program Centers of Northern Madhya Pradesh, India. Indian J Endocrinol Metab. 2017;21(4):570-6.

Restrepo BI, Schlesinger LS. Impact of diabetes on the natural history of tuberculosis. Diabetes research and clinical practice. 2014;106(2):191-9.

Prakash BC, Ravish KS, Prabhakar B, Ranganath TS, Naik B, Satyanarayana S et al. Tuberculosis-diabetes mellitus bidirectional screening at a tertiary care centre, South India. Public Health Action. 2013;3(1):18-22.